Conjunctivitis, commonly known as “pink eye,” is an inflammation of the outermost layer of the eye and the inner surface of the eyelid. Symptoms of conjunctivitis include redness in the whites of the eye, itching or burning sensation, increased tear production, and the feeling of having something in the eye.
Conjunctivitis can be caused by a number of different viruses, including adenovirus, herpes simplex virus (HSV), and enterovirus. Bacterial conjunctivitis can be caused by bacteria such as staphylococcus, streptococcus, and Haemophilus influenzae. Allergies, irritants, and contact lens use can also cause conjunctivitis.
Treatment for conjunctivitis depends on the underlying cause. Viral conjunctivitis usually resolves on its own, while bacterial forms may require antibiotic eye drops or ointment. Allergic conjunctivitis can be managed with antihistamine eye drops, while irritant conjunctivitis can be treated with lubricating eye drops.
Conjunctivitis is a common condition, with approximately 3 million cases reported in the United States each year. It is most common in children, but can affect people of any age. It is especially common in areas with poor hygiene or overcrowding. Globally, conjunctivitis is one of the leading causes of blindness, with an estimated 2.2 million people worldwide suffering from visual impairment caused by the condition.
The global Conjunctivitis market was valued at US$ 3560.1 million in 2022 and is anticipated to reach US$ 3983.8 million by 2029, witnessing a CAGR of 1.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Conjunctivitis Market available at: https://www.themarketreports.com/report/global-conjunctivitis-market-research-report
This report aims to provide a comprehensive presentation of the global market for Conjunctivitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjunctivitis.
The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1381752
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479